Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, announced today the advisory board members for Competitive Landscape, Decision Resources' web-based service that assesses the clinical potential and commercial strength of both drug development candidates and major marketed drugs for central nervous system (CNS) and metabolic disorders. The new board will provide expert insight and thought-leader input to shape compound and market assessments.

(Photo: )

"I am delighted to be part of the Decision Resources advisory board for CNS," said James A. Ferrendelli, Chairman of Neurology at the University of Texas - Houston Health Science Center. "The board boasts numerous years of experience in the neurology and psychiatry fields and will prove to be a valuable asset to Decision Resources by offering insights and advice for the company's objective, third-party analysis of the pharmaceutical and health care industries."

  Members of the boards include:   Metabolic Advisory Board    Chair:    George A. Bray, M.D.     Board:    Stephen N. Davis, M.D., F.R.C.P.    Susan Greenspan, M.D.    Hans J. Hauner, M.D.    Pierre J. Lefebvre, M.D., Ph.D.    Pierre Meunier, M.D.    CNS Advisory Board     Chair:    James A. Ferrendelli, M.D.     Board:    David Brooks, M.D.    Jeffrey L. Cummings, M.D.    Dr. Csernansky, M.D.    James C. Grotta, M.D.    David Nutt, M.D.    Jean-Marc Orgogozo, M.D.    Stephen M. Stahl, M.D., Ph.D.    Clifford Woolf, M.D., Ph.D.    About Competitive Landscape from Decision Resources 

Competitive Landscape is a web-based service that combines rigorous compound evaluation with a qualitative multi-attribute approach to enhance decision making. Competitive Landscape assesses the clinical potential and commercial strength of both drug development candidates and major marketed drugs for CNS and metabolic disorders. Compound and market assessments are shaped by expert insight and thought-leader input from Decision Resources' international CNS and metabolic advisory boards.

About Decision Resources

Decision Resources, Inc., is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The company has provided strategic information services for 30 years, assessing international pharmaceutical and health care industry trends. Visit Decision Resources at

All company brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Elizabeth Marshall    Decision Resources, Inc.    781-296-2563 


Photo: NewsCom:

AP Archive:

PRN Photo Desk, 888-776-6555 or 212-782-2840

SOURCE: Decision Resources, Inc.

CONTACT: Elizabeth Marshall of Decision Resources, Inc.,

Saturated Community-Acquired Pneumonia Drug Market to Decline from $1.3 Billion in 2001 to $1 Billion in 2011

View Now